References
- Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm. 4(6): 807-818 (2007)
- Takahashi M, Suzuki K, Kim HK, Otsuka Y, Imaizumi A, Miyashita M, Sakamoto S. Effects of curcumin supplementation on exerciseinduced oxidative stress in humans. Int J Sports Med. 35(6): 469-475 (2014) https://doi.org/10.1055/s-0033-1357185
- Sahebkar A, Mohammadi A, Atabati A, Rahiman S, Tavallaie S, Iranshahi M, Akhlaghi S, Ferns GA, Ghayour-Mobarhan M. Curcuminoids modulate pro-oxidant-antioxidant balance but not the immune response to heat shock protein 27 and oxidized LDL in obese individuals. Phytother Res. 27(12): 1883-1888 (2013) https://doi.org/10.1002/ptr.4952
- Panahi Y1, Sahebkar A, Amiri M, Davoudi SM, Beiraghdar F, Hoseininejad SL, Kolivand M. Improvement of sulphur mustardinduced chronic pruritus, quality of life and antioxidant status by curcumin: results of a randomised, double-blind, placebo-controlled trial. Br J Nutr. 108(7): 1272-1279 (2012) https://doi.org/10.1017/S0007114511006544
- Moreillon JJ, Bowden RG, Deike E, Griggs J, Wilson R, Shelmadine B, Cooke M, Beaujean A. The use of an anti-inflammatory supplement in patients with chronic kidney disease. J Complement Integr Med. 1: 10 (2013)
- Ganjali S, Sahebkar A, Mahdipour E, Jamialahmadi K, Torabi S, Akhlaghi S, Ferns G, Parizadeh SM, Ghayour-Mobarhan M. Investigation of the effects of curcumin on serum cytokines in obese individuals: a randomized controlled trial. Scientific World Journal. 11: 898361 (2014)
- Lopresti AL, Maes M, Maker GL, Hood SD, Drummond PD. Curcumin for the treatment of major depression: a randomised, doubleblind, placebo controlled study. J Affect Disord. 167: 368-375 (2014) https://doi.org/10.1016/j.jad.2014.06.001
- Henrotin Y, Gharbi M, Dierckxsens Y, Priem F, Marty M, Seidel L, Albert A, Heuse E, Bonnet V, Castermans C. Decrease of a specific biomarker of collagen degradation in osteoarthritis, Coll2-1, by treatment with highly bioavailable curcumin during an exploratory clinical trial. BMC Complement Altern Med. 17;14:159 (2014)
- Chuengsamarn S, Rattanamongkolgul S, Phonrat B, Tungtrongchitr R, Jirawatnotai S. Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial. J Nutr Biochem. 25(2): 144-150 (2014) https://doi.org/10.1016/j.jnutbio.2013.09.013
- Wahlstrom B, Blennow G. A study on the fate of curcumin in the rat. Acta Pharmacol Toxicol (Copenh). 43(2): 86-92 (1978) https://doi.org/10.1111/j.1600-0773.1978.tb02240.x
- Tonnesen HH1, Masson M, Loftsson T. Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability. Int J Pharm. 244(1-2): 127-135 (2002) https://doi.org/10.1016/S0378-5173(02)00323-X
- Sasaki H, Sunagawa Y, Takahashi K, Imaizumi A, Fukuda H, Hashimoto T, Wada H, Katanasaka Y, Kakeya H, Fujita M, Hasegawa K, Morimoto T. Innovative Preparation of Curcumin for Improved Oral Bioavailability. Pharm. Bull. 34(5): 660-665 (2011) https://doi.org/10.1248/bpb.34.660
- Yeh CC, Su YH, Lin YJ, Chen PJ, Shi CS, Chen CN, Chang HI. Evaluation of the protective effects of curcuminoid (curcumin and bisdemethoxycurcumin)-loaded liposomes against bone turnover in a cell-based model of osteoarthritis. Drug Des Devel Ther. 20;9:2285-2300 (2015)
- Yang X, Li Z, Wang N, Li L, Song L, He T, Sun L, Wang Z, Wu Q, Luo N, Yi C, Gong C. Curcumin-encapsulated polymeric micelles suppress the development of colon cancer in vitro and in vivo. Sci Rep. 18;5:10322 (2015)
- Huang L, Cai M, Xie X, Chen Y, Luo X. Uptake enhancement of curcumin encapsulated into phosphatidylcholine-shielding micelles by cancer cells. J Biomater Sci Polym Ed. 25(13): 1407-1424 (2014) https://doi.org/10.1080/09205063.2014.941261